Adapting care for older cancer patients during the COVID-19 pandemic: Recommendations from the International Society of Geriatric Oncology (SIOG) COVID-19 Working Group.

Filiaciones

Battisti NML:

Breast Unit, Department of Medicine Department, The Royal Marsden NHS Foundation Trust, Breast Cancer Research Division, The Institute of Cancer Research, London, UK

Mislang AR:

Department of Medical Oncology, Flinders Centre for Innovation in Cancer, Bedford Park, SA, Australia

Cooper L:

Division of Aging, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA

O'Donovan A:

Discipline of Radiation Therapy, Trinity College, Dublin, Ireland

Audisio RA:

Department of surgery, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

Cheung KL:

School of Medicine, University of Nottingham, Royal Derby Hospital Centre, Derby, UK

Sarrió RG:

Department of Medical Oncology, Hospital Universitari i Politècnic La Fe, Valencia, Spain

Stauder R:

Department of Internal Medicine V (Haematology and Oncology), Innsbruck Medical University, Innsbruck, Austria

Soto-Perez-de-Celis E:

Department of Geriatrics, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico

Jaklitsch M:

Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA

Williams GR:

Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham School of Medicine, Birmingham, AL, USA

O'Hanlon S:

University College Dublin, St Vincent's University Hospital, Dublin, Ireland

Alam M:

Pfizer Oncology, Asia Pacific Region, Australia

Cairo C:

National Integrated Cancer Control Program, Department of Health, Manila, Philippines

Colloca G:

Policlinico A. Gemelli, Rome, Italy

Gil LA:

Geriatric Division, São Paulo University, São Paulo, Brazil

Sattar S:

College of Nursing, University of Saskatchewan, Regina, Canada

Kantilal K:

School of Pharmacy, University of East Anglia, Norwich, UK

Russo C:

Department of Medical Oncology, Centre Léon Bérard, Regional Comprehensive Cancer Centre, Claude-Bernard Lyon-1 University, Lyon, France

Lichtman SM:

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA

Brain E:

Department of Medical Oncology, Institut Curie/Saint-Cloud, Paris, France

Kanesvaran R:

Department of Medical Oncology, National Cancer Centre Singapore, Singapore

Wildiers H:

Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium